Abstract:Heart failure is the terminal stage of many cardiac diseases, in which β1-adrenoceptor (β1-AR) autoantibody (β1-AA) has a causative role. By continuously activating β1-AR, β1-AA can induce cytotoxicity, leading to cardiomyocyte apoptosis and heart dysfunction. However, the mechanism underlying the persistent activation of β1-AR by β1-AA is not fully understood. Receptor endocytosis has a critical role in terminating signals over time. β2-adrenoceptor (β2-AR) is involved in the regulation of β1-AR signaling. This research aimed to clarify the mechanism of the β1-AA-induced sustained activation of β1-AR and explore the role of the β2-AR/Gi-signaling pathway in this process. The beating frequency of neonatal rat cardiomyocytes, cyclic adenosine monophosphate content, and intracellular Ca2+ levels were examined to detect the activation of β1-AA. Total internal reflection fluorescence microscopy was used to detect the endocytosis of β1-AR. ICI118551 was used to assess β2-AR/Gi function in β1-AR sustained activation induced by β1-AA in vitro and in vivo. Monoclonal β1-AA derived from a mouse hybridoma could continuously activate β1-AR. β1-AA-restricted β1-AR endocytosis, which was reversed by overexpressing the endocytosis scaffold protein β-arrestin1/2, resulting in the cessation of β1-AR signaling. β2-AR could promote β1-AR endocytosis, as demonstrated by overexpressing/interfering with β2-AR in HL-1 cells, whereas β1-AA inhibited the binding of β2-AR to β1-AR, as determined by surface plasmon resonance. ICI118551 biasedly activated the β2-AR/Gi/G protein-coupled receptor kinase 2 (GRK2) pathway, leading to the arrest of limited endocytosis and continuous activation of β1-AR by β1-AA in vitro. In vivo, ICI118551 treatment attenuated myocardial fiber rupture and left ventricular dysfunction in β1-AA-positive mice. This study showed that β1-AA continuously activated β1-AR by inhibiting receptor endocytosis. Biased activation of the β2-AR/Gi/GRK2 signaling pathway could promote β1-AR endocytosis restricted by β1-AA, terminate signal transduction, and alleviate heart damage.

Β3-Adrenergic Receptor Activation Induces TGFβ1 Expression in Cardiomyocytes Via the PKG/JNK/c-Jun Pathway.

EphrinB2 Regulates Cardiac Fibrosis Through Modulating the Interaction of Stat3 and TGF-β/Smad3 Signaling

JAK/STAT3 signaling pathway is involved in α1-AR-mediated cardiac hypertrophy

Smad3 Mediates Cardiac Inflammation and Fibrosis in Angiotensin II–Induced Hypertensive Cardiac Remodeling

Transactivated EGFR Mediates Α₁-Ar-induced STAT3 Activation and Cardiac Hypertrophy.

Different Roles Of Bag3 In Cardiac Physiological Hypertrophy And Pathological Remodeling

Biased Activation of Β2-Ar/gi/grk2 Signal Pathway Attenuated Β1-Ar Sustained Activation Induced by Β1-Adrenergic Receptor Autoantibody

Distinct Beta-Adrenergic Receptor Subtype Signaling in the Heart and Their Pathophysiological Relevance.

Beta-adrenoceptor Signaling Pathways Mediate Cardiac Pathological Remodeling.

Gi-biased Β2ar Signaling Links GRK2 Upregulation to Heart Failure.

Angiotensin II Causes Biphasic STAT3 Activation Through TLR4 to Initiate Cardiac Remodeling

20(S)-ginsenoside Rg3 exerts anti-fibrotic effect after myocardial infarction by alleviation of fibroblasts proliferation and collagen deposition through TGFBR1 signaling pathways

Subtype-specific Beta-Adrenoceptor Signaling Pathways in the Heart and Their Potential Clinical Implications.

Activation of Peroxisome Proliferator-Activated Receptor γ (PPARγ) Through NF-κB/Brg1 and TGF-ß1 Pathways Attenuates Cardiac Remodeling in Pressure-Overloaded Rat Hearts

Activating Transcription Factor 3 Deficiency Promotes Cardiac Hypertrophy, Dysfunction, And Fibrosis Induced By Pressure Overload

The gp130/STAT3 signaling pathway mediates β-adrenergic receptor-induced atrial natriuretic factor expression in cardiomyocytes

Internalized β2-Adrenergic Receptors Oppose PLC-Dependent Hypertrophic Signaling

Crosstalk between angiotensin II and platelet derived growth factor-BB mediated signal pathways in cardiomyocytes

Krüppel-like Factor 4 Transcriptionally Regulates TGF-β1 and Contributes to Cardiac Myofibroblast Differentiation.

Emerging Concepts and Therapeutic Implications of Β-Adrenergic Receptor Subtype Signaling

Transforming growth factor-β and bone morphogenetic protein signaling pathways in pathological cardiac hypertrophy